Literature DB >> 25834527

Does parents' socio-economic status matter in intentions of vaccinating against human papillomavirus for adolescent daughters?

Frank Pan1, Hui-Gan Shu2.   

Abstract

BACKGROUND: The Human Papilloma Virus (HPV) vaccination provides substantial protection, and it is best to be taken before the age of twelve. Taiwan approved HPV vaccines since 2006. However, very few female adolescent have been vaccinated until now.
OBJECTIVES: To examine whether the parents' socio-economic status matters in deciding to purchase HPV vaccination for their daughters based on the theory of planned behavior.
METHOD: A structured questionnaire to collect 394 responses from parents of adolescent girls in Taiwan. Data was coded to categorize relevant socio-economic classes, and was analyzed with SPSS.
RESULTS: The behavior intentions of parents with low (mean= 5.28) and high (5.01) socio-economic status are significantly stronger than the moderate (4.56) in deciding to purchase the HPV vaccination. Socio-economic factor has a slightly negative impact (B= -0.08), and attitude (0.68), subjective norms (0.16), and behavior control (0.32) have positive impacts on the parents' intention.
CONCLUSION: Major impacts on the decision to purchase an HPV vaccination for their adolescent was not due to the parents' socio-economic status but the parent's attitude. As the major predictor of a less complicated decision, attitudes toward the HPV vaccination should be reinforced through continuous communications between service providers and patient-advocate groups.

Entities:  

Keywords:  Human Papillomavirus; adolescent; cervical cancer; theory of planned behavior; vaccination

Mesh:

Substances:

Year:  2015        PMID: 25834527      PMCID: PMC4370144          DOI: 10.4314/ahs.v15i1.4

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  17 in total

1.  Finding a vaccine for human papillomavirus.

Authors:  Ian H Frazer; John Cox
Journal:  Lancet       Date:  2006-06-24       Impact factor: 79.321

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

Review 3.  Predictive, personalized, preventive, participatory (P4) cancer medicine.

Authors:  Leroy Hood; Stephen H Friend
Journal:  Nat Rev Clin Oncol       Date:  2011-03       Impact factor: 66.675

4.  Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

Authors:  Jennifer S Smith; Lisa Lindsay; Brooke Hoots; Jessica Keys; Silvia Franceschi; Rachel Winer; Gary M Clifford
Journal:  Int J Cancer       Date:  2007-08-01       Impact factor: 7.396

5.  HPV vaccination and the effect of information framing on intentions and behaviour: an application of the theory of planned behaviour and moral norm.

Authors:  Ilona Juraskova; Michaeley O'Brien; Barbara Mullan; Royena Bari; Rebekah Laidsaar-Powell; Kirsten McCaffery
Journal:  Int J Behav Med       Date:  2012-12

6.  Predictors of HPV vaccination uptake: a longitudinal study among parents.

Authors:  R Hofman; P van Empelen; J H Richardus; I M C M de Kok; H J de Koning; M van Ballegooijen; I J Korfage
Journal:  Health Educ Res       Date:  2013-09-16

Review 7.  Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control.

Authors:  Eduardo L Franco; Diane M Harper
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

8.  Health care decision making by mothers for their adolescent daughters regarding the quadrivalent HPV vaccine.

Authors:  S Paige Hertweck; A Scott LaJoie; Melissa D Pinto; Laura Flamini; Tania Lynch; M Cynthia Logsdon
Journal:  J Pediatr Adolesc Gynecol       Date:  2013-04       Impact factor: 1.814

9.  Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

Authors:  Diane M Harper; Eduardo L Franco; Cosette Wheeler; Daron G Ferris; David Jenkins; Anne Schuind; Toufik Zahaf; Bruce Innis; Paulo Naud; Newton S De Carvalho; Cecilia M Roteli-Martins; Julio Teixeira; Mark M Blatter; Abner P Korn; Wim Quint; Gary Dubin
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

10.  From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine.

Authors:  Erfan Younesi; Martin Hofmann-Apitius
Journal:  EPMA J       Date:  2013-11-06       Impact factor: 6.543

View more
  1 in total

1.  From Ebola in the slums of East and West Africa to NCDs, mental, child and reproductive health.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.